跳至主要内容
临床试验/NL-OMON26563
NL-OMON26563尚未招募不适用

The perioperative renal and metabolic outcomes after sodium glucose cotransporter 2 inhibitor in cardiac surgery – an open-label phase IV randomized controlled trial

Amsterdam UMC location AMC0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 18 to 90 years old (inclusive)
  • Undergoing elective cardiac surgery with cardio-pulmonary bypass.
  • Providing informed consent

排除标准

  • Current treatment with SGLT2 inhibitors.
  • Diabetes Mellitus Type 1
  • BMI<25 for people with type 2 diabetes
  • Reduced renal function at baseline with eGFR < 30 ml/min.
  • Systolic blood pressure < 100 mmHg at time of inclusion.
  • Emergency surgery, defined as in need of surgery for medical reasons < 7 days, i.e. S1-4” according to the Amsterdam UMC classification.
  • Female of child-bearing potential who is pregnant, breast-feeding or intend to become pregnant or is not using adequate contraceptive methods.
  • Known or suspected allergy to trial products or other drugs in the same class.

研究者

发起方
Amsterdam UMC location AMC

相似试验